Which of the following is not a goal of their treatment?

The identification of persistent craving for opioids as not a goal of treatment aligns with the objectives of Medication-Assisted Treatment (MAT). MAT primarily aims to help individuals overcome opioid use disorder. Central to this treatment is the reduction or elimination of cravings, which can lead to relapse if not addressed effectively.

By using medications such as buprenorphine or methadone, the goal is to stabilize patients, alleviate withdrawal symptoms, and reduce cravings. Discontinued use of illicit opioids, stable medication administration without withdrawal, and improvement in overall functional capacity are all integral elements of MAT. Each of these goals supports the primary aim of helping individuals achieve and maintain recovery while living productive lives free from the complications of opioid dependence.

Cravings are a symptom of addiction and, rather than being a goal, the treatment seeks to minimize these urges to promote successful outcomes and long-term recovery.